Arcadia Biosciences partners with GoodMills Innovation in Europe

US-based agricultural biotechnology company Arcadia Biosciences has collaborated with GoodMills Innovation to sell its GoodWheat product across Europe.

The company claims that GoodWheat contains higher fibre content, fewer calories and has reduced allergenicity, with an extended shelf life.

The ingredients in GoodWheat are said to be the output of Arcadia’s ArcaTech platform, which has been designed to develop new wheat varieties using advanced non-GM techniques.

Arcadia Biosciences president and CEO Matthew Plavan said: “We are pleased to be working with GoodMills to introduce valued nutritional benefits to wheat-based products across Europe.

“GoodMills is an excellent partner with a strong focus on innovation. Together, we aim to introduce uniquely healthy products for the retail, consumer and foodservice sectors in Europe, beginning in 2020.”

Based in Vienna, Austria, GoodMills Group is one of the major milling companies in Europe, with 2.9 million tonnes of grain processing capacity. Its subsidiaries are located in Bulgaria, Czech Republic, Germany, Hungary, Poland and Romania.

GoodMills innovation head Michael Gusko said: “GoodMills Innovation is recognised as one of the world’s leading innovators in the area of grain-based ingredients that are both highly functional and nutritional.

“Recent market research highlights accelerated key consumer trends in 2020, including health and immunity enhancement, natural authentic cooking and sustainable plant protein. We see tremendous potential in Arcadia’s portfolio of speciality wheats to help us meet these trends.”

Last August, Arcadia Biosciences signed an agreement with Arista Cereal Technologies and Bay State Milling Company to commercialise its high-fibre resistant starch wheat in North America, Europe and parts of Asia.